Wheat bran fibre has a beneficial effect on gastrointestinal function, but evidence for wheat germ is scarce. Accordingly, we evaluated the effects of daily intake of wheat germ on gastrointestinal discomfort and gut microbiota by adding wheat germ to refined (white) wheat bread, the most consumed bread type. We hypothesised that an improvement in the composition of refined bread could beneficially affect intestinal health without compromising consumers’ acceptance.
Fifty-five healthy adults were recruited for a randomised, double-blind, crossover, controlled trial comprising two 4-week intervention periods separated by a 5-week washout stage. During the first 4-week period, one group consumed wheat bread enriched with 6 g of wheat germ and the control group consumed non-enriched wheat bread.
Wheat germ-enriched bread was well-appreciated and the number of participants that demonstrated minimal gastrointestinal improvements after wheat-germ intake was higher than in the control arm. Importantly, intake of wheat germ-enriched bread decreased the perceived gastrointestinal discomfort-related quality of life (subscale worries and concerns) over refined white bread. The improvements in the gastrointestinal function were accompanied by favourable changes in gut microbiota, increasing the number of Bacteroides spp. and Bifidobacterium spp.
Adding wheat germ to industrially made white bread without altering sensory properties may promote a healthy gut bacterial microbiota and the gastrointestinal health.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Wei R, Ross AB, Su M, Wang J, Guiraud SP, Draper CF, Beaumont M, Jia W, Martin FP (2018) Metabotypes related to meat and vegetable intake reflect microbial, lipid and amino acid metabolism in healthy people. Mol Nutr Food Res 62(21):e1800583. https://doi.org/10.1002/mnfr.201800583
Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A (2016) The gut microbiota and host health: a new clinical frontier. Gut 65(2):330–339. https://doi.org/10.1136/gutjnl-2015-309990
Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375(24):2369–2379. https://doi.org/10.1056/NEJMra1600266
Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489(7415):220–230. https://doi.org/10.1038/nature11550
Simrén M (2018) Manipulating the gut microbiome as a treatment strategy for functional gastrointestinal disorders. Gastroenterology 155(4):960–962. https://doi.org/10.1053/j.gastro.2018.09.008
Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG, Rome Foundation C (2013) Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62(1):159–176. https://doi.org/10.1136/gutjnl-2012-302167
De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107(33):14691–14696. https://doi.org/10.1073/pnas.1005963107
Holscher HD (2017) Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8(2):172–184. https://doi.org/10.1080/19490976.2017.1290756
Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G (2017) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491–502. https://doi.org/10.1038/nrgastro.2017.75
Healey GR, Murphy R, Brough L, Butts CA, Coad J (2017) Interindividual variability in gut microbiota and host response to dietary interventions. Nutr Rev 75(12):1059–1080. https://doi.org/10.1093/nutrit/nux062
Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, Avnit-Sagi T, Kosower N, Malka G, Rein M, Suez J, Goldberg BZ, Weinberger A, Levy AA, Elinav E, Segal E (2017) Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses. Cell Metab 25(6):1243–1253e1245. https://doi.org/10.1016/j.cmet.2017.05.002
Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalova L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E, Segal E (2015) Personalized nutrition by prediction of glycemic responses. Cell 163(5):1079–1094. https://doi.org/10.1016/j.cell.2015.11.001
de Roos B, Brennan L (2017) Personalised interventions—a precision approach for the next generation of dietary intervention studies. Nutrients. https://doi.org/10.3390/nu9080847
Fardet A (2010) New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev 23(1):65–134. https://doi.org/10.1017/S0954422410000041
EFSA (2010) European Food Safety Authority. Scientific Opinion on the substantiation of health claims related to wheat bran fibre and increase in faecal bulk (ID 3066), reduction in intestinal transit time (ID 828, 839, 3067, 4699) and contribution to the maintenance or achievement of a normal body weight (ID 829) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J 8(10):1817. http://www.efsa.europa.eu/en/efsajournal/pub/1817. Accessed 13 Jan 2016
Muller-Lissner SA (1988) Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis. Br Med J (Clin Res Ed) 296(6622):615–617
Muir JG, Yeow EG, Keogh J, Pizzey C, Bird AR, Sharpe K, O’Dea K, Macrae FA (2004) Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone. Am J Clin Nutr 79(6):1020–1028. https://doi.org/10.1093/ajcn/79.6.1020
Rees G, Davies J, Thompson R, Parker M, Liepins P (2005) Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome. J R Soc Promot Health 125(1):30–34
Jenkins DJ, Peterson RD, Thorne MJ, Ferguson PW (1987) Wheat fiber and laxation: dose response and equilibration time. Am J Gastroenterol 82(12):1259–1263
Healey G, Murphy R, Butts C, Brough L, Whelan K, Coad J (2018) Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. Br J Nutr 119(2):176–189. https://doi.org/10.1017/S0007114517003440
Lim CC, Ferguson LR, Tannock GW (2005) Dietary fibres as “prebiotics”: implications for colorectal cancer. Mol Nutr Food Res 49(6):609–619. https://doi.org/10.1002/mnfr.200500015
Le Bourgot C, Apper E, Blat S, Respondek F (2018) Fructo-oligosaccharides and glucose homeostasis: a systematic review and meta-analysis in animal models. Nutr Metab (Lond) 15:9. https://doi.org/10.1186/s12986-018-0245-3
Poeker SA, Geirnaert A, Berchtold L, Greppi A, Krych L, Steinert RE, de Wouters T, Lacroix C (2018) Understanding the prebiotic potential of different dietary fibers using an in vitro continuous adult fermentation model (PolyFermS). Sci Rep 8(1):4318. https://doi.org/10.1038/s41598-018-22438-y
Arrigonia E, Jorger F, Kolloffel B, Rouleta I, Herenspergerb M, Meileb L, Amadò R (2002) In vitro fermentability of a commercial wheat germ preparation and its impact on the growth of bifidobacteria. Food Res Int 35(5):475–481. https://doi.org/10.1016/S0963-9969(01)00146-6
Matteuzzi D, Swennen E, Rossi M, Hartman T, Lebet V (2004) Prebiotic effects of a wheat germ preparation in human healthy subjects. Food Microbiol 21:119–124. https://doi.org/10.1016/S0740-0020(03)00009-1
Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O’Sullivan O, Fitzgerald GF, Deane J, O’Connor M, Harnedy N, O’Connor K, O’Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O’Toole PW (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488(7410):178–184. https://doi.org/10.1038/nature11319
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130(5):1480–1491. https://doi.org/10.1053/j.gastro.2005.11.061
Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH (2008) Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol 103(5):1241–1248. https://doi.org/10.1111/j.1572-0241.2007.01755.x
Moreira-Rosario A, Pinheiro H, Calhau C, Azevedo LF (2016) Can wheat germ have a beneficial effect on human health? A study protocol for a randomised crossover controlled trial to evaluate its health effects. BMJ Open 6(11):e013098. https://doi.org/10.1136/bmjopen-2016-013098
Moreira-Rosario A, Pinheiro H, Marques C, Teixeira JA, Calhau C, Azevedo LF (2019) Does intake of bread supplemented with wheat germ have a preventive role on cardiovascular disease risk markers in healthy volunteers? A randomised, controlled, crossover trial. BMJ Open 9(1):e023662. https://doi.org/10.1136/bmjopen-2018-023662
Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr (1999) Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 34(9):870–877
Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE (1999) Psychosocial aspects of the functional gastrointestinal disorders. Gut 45(Suppl 2):II25–II30
Pais-Ribeiro J, Marques T (2009) A avaliação do stresse: a propósito de um estudo de adaptação da escala de percepção de stresse. Psicologia Saúde Doenças 10:237–248
Dubois D, Gilet H, Viala-Danten M, Tack J (2010) Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation. Neurogastroenterol Motil 22(2):e54–e63. https://doi.org/10.1111/j.1365-2982.2009.01408.x
Pocock SJ (1983) Clinical trials: a practical approach. Wiley, Chichester
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57:289–300
Kleerebezem M, Vaughan EE (2009) Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 63:269–290. https://doi.org/10.1146/annurev.micro.091208.073341
O’Neill I, Schofield Z, Hall LJ (2017) Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases. Emerg Top Life Sci 1(4):333–349. https://doi.org/10.1042/ETLS20170058
Zhou Y, Zhi F (2016) Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: a meta-analysis. Biomed Res Int 2016:5828959. https://doi.org/10.1155/2016/5828959
Romani-Perez M, Agusti A, Sanz Y (2017) Innovation in microbiome-based strategies for promoting metabolic health. Curr Opin Clin Nutr Metab Care 20(6):484–491. https://doi.org/10.1097/MCO.0000000000000419
Schwalm ND 3rd, Groisman EA (2017) Navigating the gut buffet: control of polysaccharide utilization in Bacteroides spp. Trends Microbiol 25(12):1005–1015. https://doi.org/10.1016/j.tim.2017.06.009
Tamanai-Shacoori Z, Smida I, Bousarghin L, Loreal O, Meuric V, Fong SB, Bonnaure-Mallet M, Jolivet-Gougeon A (2017) Roseburia spp.: a marker of health? Future Microbiol 12:157–170. https://doi.org/10.2217/fmb-2016-0130
Fais T, Delmas J, Cougnoux A, Dalmasso G, Bonnet R (2016) Targeting colorectal cancer-associated bacteria: a new area of research for personalized treatments. Gut Microbes 7(4):329–333. https://doi.org/10.1080/19490976.2016.1155020
Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489(7415):242–249. https://doi.org/10.1038/nature11552
Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L, Consortium MI-O, Dumas ME, Rizkalla SW, Dore J, Cani PD, Clement K (2016) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65(3):426–436. https://doi.org/10.1136/gutjnl-2014-308778
Burton PM, Monro JA, Alvarez L, Gallagher E (2011) Glycemic impact and health: new horizons in white bread formulations. Crit Rev Food Sci Nutr 51(10):965–982. https://doi.org/10.1080/10408398.2010.491584
Whitton C, Nicholson SK, Roberts C, Prynne CJ, Pot GK, Olson A, Fitt E, Cole D, Teucher B, Bates B, Henderson H, Pigott S, Deverill C, Swan G, Stephen AM (2011) National Diet and Nutrition Survey: UK food consumption and nutrient intakes from the first year of the rolling programme and comparisons with previous surveys. Br J Nutr 106(12):1899–1914. https://doi.org/10.1017/S0007114511002340
Tack J, Stanghellini V, Dubois D, Joseph A, Vandeplassche L, Kerstens R (2014) Effect of prucalopride on symptoms of chronic constipation. Neurogastroenterol Motil 26(1):21–27. https://doi.org/10.1111/nmo.12217
Tack J, Camilleri M, Dubois D, Vandeplassche L, Joseph A, Kerstens R (2015) Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride. Neurogastroenterol Motil 27(3):397–405. https://doi.org/10.1111/nmo.12505
AM-R, CC, and LFA were responsible for the study design, carrying out the trial, data analysis, manuscript writing, and final revision. CM, HP, SN and DS were partially responsible for the data collection and analysis. JAT collaborated in the study design and final revision of the manuscript. AM-R and LFA were responsible for the statistical analysis. CC and LFA were coordinators of the project, with an equal contribution. This work is part of the VALORINTEGRADOR project, and was supported by the Programa Operacional Competitividade e Internacionalização and by National Funds through the Fundação para a Ciência e a Tecnologia (through the operations FCOMP-01-0202-FEDER-038861 and POCI-01-0145-FEDER-007746). Our thanks to Germen and Padaria Ribeiro for the production of the bread used in this trial. We would like to thank Francisca Mendes for her assistance in laboratory work. We are also especially grateful to all participants for their enthusiastic collaboration in this study. We extend our thanks to Milaydis Sosa-Napolskij for proof reading this manuscript.
Conflict of interest
None of the authors has any conflict of interest regarding this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Moreira-Rosário, A., Marques, C., Pinheiro, H. et al. Daily intake of wheat germ-enriched bread may promote a healthy gut bacterial microbiota: a randomised controlled trial. Eur J Nutr 59, 1951–1961 (2020). https://doi.org/10.1007/s00394-019-02045-x
- Gastrointestinal discomfort
- Gut microbiota
- Wheat germ
- Randomised controlled trial